In hepatocellular carcinoma (HCC), targeting the integrin αvβ5 pathway or the CCL15-CCR1 axis may disrupt the reciprocal activation between SPP1+ macrophages and cancer stem cells, potentially overcoming chemo-resistance. The gene discussed is SPP1; the disease is cancer.